scott52
$CDXS Finally got around to listening to the Cantor Fitzgerald chat. Not a whole lot to take away from it, the questions were all quite rudimentary. But Alison continues to very voearly outline the opportunity and their multi track strategy.
My takeaway is this: we're early. Really early. So early we are essentially wrong. One CDMO win. One more BP siRNA product win. And we're off the all-time lows, which is honestly all i care about at this juncture. If it just gets back to $3.X we'll all stop bitching and moaning because this beat down sucks ass.
I'm giving them til 1/1/28. If they don't have everything in place by then, I think it's pointless. But I suspect things will start coming together in early 2027.
Until then...zzzzzzzz.
4
